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In this study. we attempted to identify and characterize 
transformation-induced cell-surface glycoproteins of human 
keratinocytcs. Therefore, we first searched for glycoprotcins 
which arc sigmficantly elevated in human keratinocytes after 
transformation and immortalization by SV 40 virus and 
which arc also found at high levels in keratinocytic cell lines 
derived from squamous cell carcinomas of the skin. Out of at 
least 80 different cell-surface antigenic systems of human 
tumor cell~. only three glycoprotcins showed elevated ex-
pre~sion 111 transformed keratinocytes. Among these, a 
38-kD glycoprotein (gp 38) was highly mcreased in all trans-
formed keratinocytc cell lines tested, but was not elevated in 
transformed fibroblasts. The expression of gp 38 was further 
characterized in normal epidermis and in its benign and rna-
S mce the development of hybndomJ technology, numer-om monoclonal annbod1e~ have been rai~ed agamst cell-surface anti gem of maltgnant hunun tumor~. It was the general ann to develop valuable tools for diagnom and trcJtment of cancer and for the ~rudy of tumor biology. In 
most cases, It remam<."d unclear whether the expression of these 
cell-~urface .umgens was associated with the process of maltgnant 
transformanon.ln th1s and a rrcent study (I] It was our goal to ~elect 
and characterize human tumor antigen~ of potential relevance for 
cell tramfonnarton. Our pnmary criterion for an antigen of interest 
on the ~urface of rumor cells w~ 1ts mcrease after transfonnanon 
and unmortahzatton by SV40 virus in vitro or after oncogenic 
event~ 111 v1vo. Among Jt lea\t 80 different anngenic systems of 
human tumor ct.'lb, which had been defined previously ([2 16], 
unpublished), only three glycoproteins (gp 130, gp 90, and gp 38) 
showed up-regulation after transformation by SV40 virus. Gp 38 
appeared pnmanly associatt.'d w1th cell transformation of keratrno-
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lignant hyperproliferauve disorders: gp 38 was generally not 
expressed in normal epidermis and in benign hyperprolifera-
tive disorders. In contrast, strong and homogeneous reactiv-
ity was found in ~olid and fibrosing basal cell carcinomas, 
whereas no or low reactivity wa.!> detected in squamous cell 
carcinoma~ and in those parts of BCC revealing keratotic 
differentiation. Interestingly, high expression of gp 38 was 
also found in primary epithelial germs offetal skin, secondary 
germ cells of the tclogenic hair follicle and secretory tubules 
of sweat glands. The immunohistologic data suggest that gp 
38 is preferentially expressed by epidermal cells which lack 
squamous and pilosebaceous differentiation.] frn,est Dermatol 
95:74-82, 1990 
eyre~. ~1nce 1t was lughly Increased in all transformed keratmocyte 
cell I me\ but was not elevated m transformed fibroblasts. Recently, 
we reported the characterization of one of the other two glycopro-
tems (gp 130) which was primarily mcre~cd 111 fihroblam aft<."r 
SV40 rramformanon [ 1 ]. In th1s paper, we report on the character-
ization of gp 38 in norm.1l and transformed keratinocyte~ and de-
scribr m restncted expres\IOn in normal and d1seased skm. 
MAThRIALS AND METHODS 
Cells a nd C ulture Conditions Human cell lines and short-term 
cultures were maintamed 111 RPM! 1640 supplemented with 2 mM 
gluwmne, t% nonessential ammo ac1ds. I 00 U / ml pemcillm, and 
I 00 U /ml ~treptomyctn. Prnnary cultures of normal kerannocyt<."S 
were established as prrv10usly descnbed by Emnger et al [I 7J. Tis-
sue culture mcd1a rounnely contamed 10% fetal bovme serum 
(FBS). Thl· cdl lines SCLl and SCLII denved from squamou!. cell 
carnnoma\ of the skm, the SV40 transformed k<."ratinocyte cell line 
I ISV-4. and the ras-oncogcne-transformed keratinocyte cell hnes 
Hacar 11 / 3 and Hacat A4 were g1fts from N. E. Fusenig (German 
C.mcer Re;,earch Center (DKFZ] lleidrlberg, West Germany) 
[18, 19]. Two SV 40-transformed kemmocyte cell I inc~ ( 130 and 
425) were kmdly prov1ded by M. L. Stemberg (Department of Pa-
thology, New York Umvermy Med1cal Center. NY) [20]. Normal 
fet.ll and .1dult fibroblasts were estabhshed and maintained in culture 
as prevwu~ly descnbed I I]. SV40 Vlnl\-transformed fibroblasts and 
the1r normal parent cell line were obtained from H. L. Ozer (De-
partment of Microbiology and Molecular Genetics, Univermy of 
Med1c111e and Denmtry of New Jersey, NJ) (SV40-cell lines: 
SV /Hf-4, SV /HF-5, SV / Hr-tsA; normal parent cell 1m<.": HS74) 
[21] .1ml from the Amencan Tissue Type Culture Collection 
(ATCC, Rockvtlle, MD) (SV40-cell hoe W138 VA 13; normal par-
ent celllinr Wi38). The chemically transformed fibroblast cell lines 
(HuT12 Jnd HuT14) and their normal parent cellltne (kD) were 
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1-.md ly provided by J. Leavm , Ltnus Pauling Institute, Palo Alto, 
CA) [22]. For the study of the expression of gp 38 under dtlferent 
growth conditio ns, subconfluent kerarinocyre ce ll lines were 
rrc.•ated wtth 25 mg Mtto mycm C (Sigma C hemtcals Company. St. 
Lout~. MI) for 2 h ar 37"C and were mamramed, thereafter. m 
regular culture medtum (RPM I 1640 + 10% FBS) for 4 d. Dunng 
this period the Mtto mycin C-treated cultures revealed no mtroses 
and no increase 111 cell number. Parallel cultures were either mcu-
bated in medtum containing a lo w concentration of serum (0.5% 
Fl3S) or were mamtained under regular culture conditio ns (10% 
Fl3S). Afte r 4 d , syntheSIS of gp38 was compared m the cultures after 
metabohc labehng w1th I35Simethlonine (4 h). 
Antibody Prepar ation and Sero logy H ybndomas [2 - 16] 
were grown 111 culture or in the perito neal cavity o f Balb/c/C57 
BL6 F1 mice. Hybndoma culture supernatants were used for indi-
rect Immunofluorescence and immunoperox1dase studies of tissue 
sectiOn!.. 1 :50 d tl uted asctte~ of hybndoma beanng mice was used 
for the analysts of cell-surface Immunofluorescence by flow cyrom-
etry and 111 1mmunoprecip1tauo n studies. Roserring tests (mtxed 
hemadsorpuon J~says) (M HA) for the detection of cell-surface anti-
gens on cultured cells have been described previOusly (5,23]. 
R adio imm unoprecip itatio n Cells were metabolically labeled 
wuh j35Simethionme (60-200 Ji.C/ml, New England Nuclear, 
Bo~ton . MA) for 3, 4, and 12 h. Glycoproteins were tsolated from 
Nonidet P40 (Stgma C he1mcals Company, St. Louis, Missouri) sol-
ub1hzcd cell extracts by adsorpnon to Concanavalin A (Con A) 
(Pharmacia Inc., U ppsala, Sweden) [24). 1mmunoprectpitations 
were cam ed our as previously de~cnbed (1]. Bnefly, samples of rhe 
Con A-bound fraction ( 1.5 X I 06 cpm) were mcubated With I -
2 111 of ascttes conrauu ng MoAb for 2 h at 4 •c. lmmunocomplexes 
were then prectpttated with protein A-Sepharose C L-4B (Pharrna-
cta Inc.) preincubared with rabbit anrimouse-immunoglobulin 
(DAKO Corp., Santa Barbara, C A). After 10 washes with buffer 
(0.5% NP40, 0. 1°/o SDS, 0.15 M sodium chlonde, 0 .01 M Tns, pH 
7.5), the prenpn.ued glycoprotems were processed by SDS-PAGE 
111 7.5% or 9% acrylamtdc gels. For fluorography, gels were im-
mersed in 0.5 M sodium sa licylate for 20 min. T o compare glyco-
protein synthesis of distinct cell cultures, equal amounrs of radioac-
tiVIty o f the Con A-bound fractions were irnmunoprecipitated . The 
amounts of prectpttated protem~ were determmed by quantitative 
density scannmg of the fluorographs. 
Immunohistochemistry N ormal and diseased skin was ob-
tamed fro m b10p~1es or surgical ~pecimen in the Department of 
Dermatology of the University ofUim, after informed consent had 
been g1ven by the patients. The m sue specimens were snap frozen in 
hqmd nm ogen, embedded in OCT -compound (Miles Laboratories, 
N aperv1lle, IL) and stored .n - 135 •c until tested. Cryostat-cut 
tl~\ue sectio ns ( 4-6 Ji.m) were moun red on gelatm-coated sltdes, air 
dned, and fixed 111 cold acetone (4 "C). Indirect nnmunofluore~­
ccnce and immunopcroxidase (ABC method, Vector Laboratories, 
Burlingame, C A) rem were carried out as described (25,26]. For 
every skmles1on, the clinical dtagnosts wa~ confirmed by histopath-
ologic analvm. Prenatal skm was den vcd fro m fetuses o f 12 and 14 
weeks gestational age and was used in comphancc with human 
subj ect rcgulauons. 
Cell Staining for Analysis with the Fluo rescence-Activated 
Cell Sorter N ormal and transformed keratinocytcs were de-
tached using 2 mM EDT A (Merck Company, Car# I 0964, Darm-
mdr, FRG) or 0.05°'<> T rypsin/ 0.02% EDTA m PBS (Btochrom 
KG, Berlm, FRG). Trypsin treatment (up to 1.5 h at 37•q did not 
affect gp 38 reacnvtty. Cells were suspended in RPM ! 1640 con-
tammg 10% FCS and incubated with saturating amounts of MoAb 
for 45 min .It 4•c. Control samples were incubated with a mou~c 
Mo Ab detecting an unrelated cell-surface anugen (MoAb C NTIO, 
gp 80: M. T . J enmngs, Department of N eurology, Memorial Sloan 
Kettering Cancer Center, N ew York; unpublished) which 1~ ex-
pre~sed 111 fib roblasts and astrocytoma celllmes bur not 111 keratino-
cytcs. After rwo wa\hes with PBS, FITC-conjugated F(abh frag-
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ments of goat anti-mouse IgG (Cappel Laboratories, Cochranville, 
PA} were added for 45 m1n ar 4 •c. After three fi nal washc) m PBS, 
the cells were analyzed in a fluorescence-activated cell sorter 
(FACS) !J ]. 
RESULTS 
A 38-kD cell surface glycoprotein is htghly increased in keratmo-
cytes bur not m fibroblasts after cell transformation. In the first part 
of the study we attempted to identify cell-surface glycoproteins 
whtch are mcreased after malignant t ra nsformatio n of human cells. 
More than ISO monoclonal a ntibodie~ defin ing at lem 80 known 
cell-surface antigemc ~ysrems of human rumor cells ((2 - 16], un-
pubhshed) were rested for their differential reactivity in normal and 
transfo rmed cells. For the initial screening, mixed hernadsorprion 
assays were used. N ormal eptdermal and fibroblast cell cultures 
were compared with their SV40 vtrus or chemically transformed 
den vauves ami also w1th keraunocyre o r fibroblast cell ltnes which 
had been den ved from mahgnant human rumors. Three cell-surface 
glycoprotclm showed up-regulauon after transformation (gp 130 , 
defi ned by MoAb Q I4, R23, N9; gp 90 , defined by MoAb F8: and 
gp 38, defined by MoAb IIT29/26, H99, MI04). Gp 130 was 
high ly mcreased in 8/8 transformed fibroblast lines and m 1/7 
transformed keran nocyre I me~ (I ] (sec also T able I). Gp 90 was 
elevated 111 4/7 transformed fibroblasts and 4 j 4 kerarmocyre cell 
lines (Klem er al. manuscn pt in preparatio n) (T able I). The third 
glycoprote in - gp 38-was highly increased in all seven trans-
formed keratinocytc cell lines tested but in none of rhe fibroblast 
lines (sec also T able 1). Gp 38 was selected for further characteriza-
tion m thts study, became 1t appeared pnmanly assoctatrd wtrh the 
transformauon process of keratinocytes. 
Gp 38 IS a glycoprorem. because it bound to concanavalin A (Fig 
I A} and incorpo rated PH iglucosaminc [2]. Moreover, after treat-
ment of transformed kerari nocytc cell lines with tunicamycin, its 
molecular weight (MW} was reduced to 24 kD in immunoprecipi-
tauon rem (Fig l A) suggemng that a large part o f the molecule is 
N -lmkcd glycosylau on When gp 38 was immunoprec1pitatcd 
Table I. Cell -Surface Express1on of T hree Glycoprote111s 111 
Normal and T ransformed Keratmocytes and Fibroblasts• 
gp 38 gc 130 !4P 90 
Norm.1l cp1dcnnal culture:\ (n ... 12) - jw 
SV40-tramformcd keratl lllKytc~ 
425 
130 
HSV-4 
ra~-tran~formcd kerannocy1c~ 
llacat 11/ 3 
llac.ll A4 
SquamoU\ carctnoma cdl lmc~ 
SCLI 
SCL2 
Normal .1duh libroblasc~ (n !!) 
Normal fctJI fihroblasr~ (n .,. 6) 
SV40-tramformcd fibrob l.ms 
SV / IIF-4 
SV / IIF-5 
SV /HI--r~A 
W138 VA1 3 
ChcmtcJIIy tumform~J fihroblam 
HuT 12 
lluT 14 
F1brosarcom.t\ 
HT 1080 
8387 
sw 684 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+ ++ 
++ 
n.J. n.d. 
n.d n.d 
n.J n.d. 
+++ ++ 
w ++ 
w 
++ 
+++ ++ 
+++ ++ 
+++ n.d. 
+++ 
+++ ++ 
+++ ++ 
+++ +++ 
+++ 
+++ n.d. 
•Cr!l->urf•tr rxprrmun <>I the 1hrr r gly«>protrlm "•' "'"''"'d by fltm ntomclry 
afrer 1mluru unmunofluorr...:rlllC mmmg wnh MuAh IIT 29/ 26 (gp 311). Q14 (gp 
130). •1111 H! (gp 90). Exprr"'"" rangrd from""''~ (w) tn very strong(++ +); n.d .. nor 
donr 
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Figure 1. Fluorogwn~ of unmunoprccipttates obtamcd with anti-gp 38 
MoAb and ~eparared by SDS-PAGE. NP-40 cclllysares from rhei)5Simetht-
omne labeled tramfonncll kermnocytc cell I me 425 were used. A) Compar-
ison of gp 38 ;ynthe;ts under normal culntrc conditions (n.C.) and after 
pretreatment of culture• wtdl 5!1g/ml tunicamycin (TM) for 5 h. 425 cells 
were labeled for 60 nun. La11r J· MoAb HT29/26, gp 38; la11t 2: MoAh 
CNTI 0, control. Plc-~c- note that the molecular weight of gp 38 is rc-duccd 
to 24 kD m rumcamycm-tre;~tcd cclk B) Companson of the effiCiency of 
four dtfferent MoAh\ ro unmunopreetpttatc gp 38.425 cells were labeled for 
4 h. Con A-hound fracttons of NP-40 celllysates were used. Lallf I MoAb 
CNTIO, control~ la11r 2 MoAb H99: larrr 3. MoAb M104; larrr 4 MoAb 
HT29/26; larrr 5 · MoAb 162-21.2 after precleanng With MoAb HT29/26; 
larrt 6 MoAh 162-212; laur 7 MoAb HT29/26 ~ftcr precleanng wtth 
MoAb 162-21.2. Note that MoAb 162-21.2 precipitates gp 38 wtth lower 
effictcncy than the other MoAb. However, tt removes all gp 38 molecule, 
from the cell lysate (/~ur 7), smce no band was obtatned by the sequenttal 
preclpttatton wtth MoAb IIT29/26. 
from high expres~or kerattnocyte cell hnes, minor bands of 42- and 
35-kD molecular we1ght were seen m add1tion to the pronunant 
band of38-kD MW. These additional bands are likely ro represent 
differences 111 glycosylat1on of the molecule, since a single band was 
seen after treatment of cells with tunicamycin (Fig l A). Gp 38 1s 
defint"d by three independt"ntly established mouse MoAbs (MH99, 
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HT29/26, M 104) [2], wh1ch precipitated equal amounts of gp 38 
from metabolically labded cell cultures {Fig 1B). In a previous 
study, L1pinski et al reported on the initial charactenzation of MoAb 
162-21.2, defining a cell-surface protein expressed on human chor-
ioncarcinomas [3]. Further charactenstics of the molecule, how-
t"ver, remamed unknown. In thts study, we found that this antibody 
also detects gp 38 (Fig 1 B). MoAb 162-21.2 precipitated gp 38 with 
lower efficiency (Fig tB) than the MoAb MH 99, HT29/26, and 
M 104. However, in sequential immunoprecip1tations, it removed 
all anngen from the celllys:te, indicanng that its epicope is present 
on all gp 38 molecules (Fig lB). In immunofluorescence studies of 
tissues, MoAbs MH99, HT29/26, and 162-21.2 mtensely stained 
posmve structures, whereas MoAb M 104 revealed weaker reac-
tiVIty. 
n. KC 425 SCLl 
---~-
97 
68 
43 
25 
1 2 1 2 1 2 
Figure 2. lncrt"ascd gp 38 synthem 111 transformed kcratmocyte cdl ltncs. 
Epidcnnal ~hort-term cultures (n.KC) were .:om pared with the SV40-trans-
formnl kcratinocytc cell line (425) and the squamous carctnoma cell line 
(SCL I). Con A-bound fracttons of J35SJmerhiomne-labelcd culntres were 
prepared as described. l mmunoprcctpttatc~ were ohtamed with MoAb 
CNTIO (/aut I, control) and MoAb HT29/26 (laud, gp 38). 
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Figure 3. Ccll-surf~cc t"Xpres~IOn of gp 38m normal (n.KC). SV40-rrans-
formt"J hr;mnocylt"\ (425) and a squamous carcmoma cell !tnt" (SCLI). 
Cell\ were procc~scd for rh~ analys•s of cell-surface immunofluorescence by 
flow cywmerry 3~ dc\cnbcJ m Materials a11d Mfthods. MoAb IIT29/26 (gp 
38) and MoAh CNTIO (comrol). 
When the synrhe~is of gp 38 was compared in normal epidermal 
cultures and SV40 virus-transformed keratinocytes (425; 130, 
H SV-4}, the levels of gp 38 were very low in the normal- and IS- to 
20-fold higher in the transformed keratinocytes (Fig 2}. The analy-
sis of the cell-surface reactivity of the cultures by flow cytomerry 
revealed char the mcrease of synthesis of gp 38 was paralleled by a 
marked elevation of cell-surface expression (Fig 3}. Also, the two 
cell ltnes, whtch had been established from squamous cell carct-
nonm of rhe eptdermis, showed h tgh levels of gp 38 (Table I, Figs 2 
and 3}. 
Gp 38 Is Highly Expressed in Basal Cell C arcino m as To 
address the quemon, whether the elevation of gp 38 in transformed 
keratinocyte cell lines 1s paralleled by irs high expression m epithe-
lial rumors of the skin, we studied its expression in basal cell and 
squamous cell carcinomas, as well as in normal skin. Indirect immu-
nofluorescence and immunoperoxidase tests usmg MoAb 
HT29/26, 1199, and 162-21.2 were performed (as summarized 111 
Table 11}. In normal ep1dermis, gp 38 was generally not detectable. 
In some specimens, however, weak gp 38 reactivity was found in 
the basal and suprabasal cell layers. The only structures of normal 
38-kD SURFACE PROTEIN ON TRANSFORMED KERATINOCYTES 77 
skm conSIStently revealing high gp 38 reactivity were sweat glands, 
where;u sebaceous glands and anagen luir folltcles showed negar1ve 
results. In sweat glands, gp 38 was strongly expressed by the cells of 
the secretory tubules, whereas low reactivity was detectable in the 
duces. Fibroblasts and cap1llary endotheltum showed no reacrivity. 
lligh expression of gp 38 was found in 44/44 basal cell carcinomas 
(HCC) bur was not detectable 111 rhe ep1dermis overlying or adJacent 
co the tumor (Figs 4 and 5). Forty of the BCC were found to lack any 
s1gns of keratotic or glandular differentiation (superficial, solid, or 
fihrosmg BCC) and revea led homogeneous expression of gp 38 in 
the tumor cells. In four BCC comprising regions with keratotic 
differentiation, the undifferentiated regions of the tumors showed 
strong gp 38 reactivity whereas in the differentiated parts, weak or 
no reactivity was found. In contrast to BCC, eight highly differen-
t iated squamous cell carcinomas (SCC) of the skin showed either no 
expression of gp 38 (n = 4} or weak reactivity in a subpopulation of 
cells (n = 4, I 0-20% of cells). 
Relationship of gp 38 to Keratinocy te Proliferation To 
study a possible relationship between expression of gp 38 and cell 
proltferarion, we performed two different types of experiments . 
First, we investigated whether the expression of gp 38 was induced 
in benign ep1dermal disorders that are associated With a high prolif-
eration rare of kerarinocytes. Lesional skin of patients suffering 
from psoriasis, keratoacanthoma, and verruca vulgaris was studied 
(as summarized in Table II). No expression of gp 38 was found in 
psoria~1s (n = 6} (Fig 5} and keratoacanthoma lesions (n = 4). In 
verruca vulgaris, six of 10 lesions showed no expression of gp 38. In 
four lesions, weak reactivity was found in less than 30% of the basal 
cells and in some cells of the upper layers. These data were consist-
ent with the concept chat increased proliferation ofkeratinocytes in 
benign hyperprol iferat ive disorders is not associated with high ex-
pression of gp 38. 
T a ble II. Gp 38 ExpressiOn in Normal Fetal and Adult Skin, as 
Well as in Benign and Malignant Hyperproliferative Disorders" 
Adult skm (n = 74} 
EpidermiS 
Hair follicle 
Anagen (n = 150} 
Caragen (n = 1 0) 
Telogen (n = 15} 
Outer root sheath 
Secondary epithelial germ 
Sebaceous glands 
Sweat gland 
Secretory tubule~ 
Ductal tubules 
Psoriasis vulgaris (n = 6} 
Keratoacanthoma (n = 4} 
Verruca vulgaris (n = 10} 
Basal cell carcinoma (n = 44} 
Squamous cell carcinoma (n = 8) 
Feral skin 
Stratum germinativum 
Stratum intermcdium 
Periderm 
Primary epithelial germ 
Hm follicles 
gp 38 expression 
-jw 
-jw 
++ 
+++ 
+++ 
+ 
-jw 
+++ 
-j+ 
wj+ 
wj+ 
wj+ 
+++ 
wj+ 
'The rrsults of unmunopcroxiclase ancl1mmunoAuorrscence .uulym are mdicated as 
follows: +!-+, antigen very strongly expressed; ++, anugen strongly expressed; +. 
anugen expressed; w, antigen weakly expressed;-. anugcn not detccuble. 
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Second, we analyzed the expressiOn of gp 38 m transformed ke-
raunocyte cell hnes under different growth conditions. When the 
lines SCL2 and 425 were rreated with mitomycin C (see Cells and 
Culrure Condiuons 111 Matenals arrd Methods) to induce growth ar-
rest, synthesis of gp 38 remamed at the same level as m the un-
treated, proliferating, parallel culrures (not shown). Also, serum 
depnvation (0.5% FCS) ofSCL2 cells for 4 days dtd not affect gp 38 
synthesis (not shown). 
High Expressio n of gp 38 in Epithelia l Germ Cells o f the 
Skin The solid basal cell carcinoma is considered as an undiffer-
entiated skin tumor due to its morphologic resemblance to primary 
epithelial germs of fetal skin (27- 30] and its uniform morphology 
lackmg keratotic or glandular differentiation. Because we had 
found high expreSSion of gp 38 in solid BCC, we studied whether 
gp 38 reactivity could also be demonstrated in undifferentiated cells 
of eptthelial germs. Gp 38 was htghly expressed in pnmary eptthe-
lial gemlS of fetal skm contrastmg with significantly lower reactiv-
ity 111 the rcmammg structures of fetal epidermts, the stratum ger-
minauvum, stratum intermedlllm, and periderm (Fig 6). Moreover, 
strong reacnv•ty of gp 38 seemed strictly confined to immarure hatr 
germs and hatr pegs, because differentiating fetal ha1r folltcles (bul-
bous hair pegs) wh1ch arc directly derived from rhe h;ur pegs 
showed reduced levels (Fig 6d). Also in adult skin, h•gh expressiOn 
of gp 38 was selectively found in secondary hair germs of tclogen 
follicles, whereas no reactivity was detectable in the remaining 
structures of telogenic follicles and in the epidermis (Ftgs 5 and 7). 
In adult anagen hair follicles and sebaceous glands, gp 38 w:ll. gener-
ally nor expressed; in some anagen follicles, however, weak reacttv-
iry was found in rhe "basal cell layer" of the outer root sheath. 
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Figure 4. High expressaon of gp 38 in basal cell 
carcinomas (BCC). J ndtre~ct immunofluorescence 
staming of a frozen section of a BCC and ovcrlymg 
normal epidenms usmg MoAb H99. Note: the BCC 
shows homogeneous hagh expression of gp 38, 
whereas normal eptdermis-bctween discontinuous 
lint and arroa"lttads-reveals no reactivary. Magni6-
cauon X 100. 
DISCUSSION 
By screerung a large number of known cell-surface antigens of 
human rumor cells we have identtfied three glycoproteins, which 
reveal up-regulation in in vitro and in vivo transformed human cell 
lines. Among these three, a 38-kD glycoprotein appeared more 
closely associated with cell transformation ofkeratinocytes, because 
it was elevated in all seven transformed keratinocyre cell lines tested 
bur not in fibroblasts after viral or chemical transformation. The 
mcrease of gp 38 in kerarinocytes seemed not to be linked to a 
specific transforming agent, because it was up-regulated in SV40 
vmts-transformed keratinocyte cell lines as well as in in vivo trans-
formed rumor cell lines derived from squamous carcinomas of the 
skm. Interestingly, the subsequent immunohistologic characteriza-
tion of epithelial skin tumors with anti gp 38 MoAb revealed that, in 
vivo, high expression of gp 38 is restricted to basal cell carcinomas, a 
ntmor type, which usually lacks squamous, pilosebaceous, or glan-
dular differentiation. In contrast, highly differentiated squamous 
cell carcinomas of the skin either revealed no gp 38 reactivity or 
showed low expression in a minor subset of rumor cells. This lead us 
to hypothesize that, in epithelial tumors of the skin, high expression 
of gp 38 might be mversely correlated to differentiation. The con-
cept is ~upported by our observation that, in keratotic BCC, gp 38 
reacrivtty was not detectable in areas of the rumors showing squa-
mous differentiation, whereas strong reactivity was found in the 
undifferentiated regions. Furthermore, cell-surface glycoproteins, 
which are preferentially expressed by keratinocytes undergoing 
squamous differentiation (gp 80, gp 40- 50) (31] revealed the re-
verse expression pattern (unpublished). The puzzling observation 
that gp 38 expression was high in cell lines derived from squamous 
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Figure 5. Expression of gp 38m normal and diseased skin. Frozen sectaons were analyzed by indirect immunopcroxidase staming using MoAb H99. a) Solid 
basal cell carcmoma and overlymg cpidennis. Magnification X 250. b) Psoriasis vulgaris. Magnification X 250. c) Solid BCC and surrounding lympho-histio-
cytic infiltrate. Magnification X250. d) Telogcnic hair follicle . Magnification X400. 
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Figure 6. High cxprc~ston of ~p 38m pnmary cplthchal germs. lmrnunofluorc:sccnce analym of fecal skin (14 week~) u\mg MoAb H99. Germs at various 
srage5 of dcvelopmcm are dtsplayed. a) Hatr germ. b) and c) later sragcs ofh:ur gcnn (b) and hatr peg (c). d) Marunng hatr follicle (bulbous hatr peg) (oblique 
cut) (amm•lrcads) Note: Htgh expression of gp 38 is selectively found 111 the und.!ferennated germs and apparenth down-regulated upon dtfferemianon (sec 
the bulbou\ hatr peg). Magruliwion X 250. 
carcmoma~ of the \kin, but was low or not detectable In sec in 
v1vo, could also be explained by this concept, because, 111 contrast to 
SC(" In VIVO, SCC CCII hnes Jack squamOUS differentiatiOn under 
normal culture cond1nons. llowever, lack of squamous d1fferenria-
t1on alone cannot be suffictent for h1gh cxpress1on of gp 38 m 
ep1dermal cell, in v1tro, bccau~e normal epidermal cell cultures 
under standard culture conditions did not express high levels of gp 
38. The additional requirements necessary to induce gp 38 111 cul-
tured keratinocytes arc apparendy generated during the process of 
cell tramformation. Future stud1cs to test rillS concept should m-
clude expcnments addressmg whether g_p 38 is down-regulated in 
squamous carcmoma cell lmt>\ upon differenuanon 111 VItro (e.g., 
d1fferennatton of cells suspended 111 methylcellulose contammg 
se1m~oltd media or in organotvp1cal culture at the air-hqt~~d Inter-
face [32]) and also whether gp 38lcvels decrease under non-permis-
sive condinons in keratinocytcs tramformed w1th oncogene mu-
tants whtch arc temperature sensinvc for the transformed 
phenotype. 
Morpholog1c stud1es have suggested that the plunpotent cell~ of 
pnmary epithcltal genm 111 fetal skm and those of secondary ha1r 
germs 111 adult skm are undifferentiated and lack pilosebaceous dlf-
fcrenn.mon. These cells aho expressed high levels of gp 38. In 
prcv1ous srud1es, the compamon ofbasal cell carcmomas {HCC) and 
primary epithelial germ~ revealed morphologic and ultr.lstrucrural 
suntlaritics [27 - 30]. Ha.,ed on these results, the concept has been 
put forward that HCC arc denvcd either from dormant cp1theltal 
gcnm or from pluripotent epuhclial cells, which are formed con-
tinuou..,ly during life [28,33). Although our finding of gp 38 being 
strongly expressed in both BCC and epithelial germs cannot con-
firm these theories of tumongenc~i~, It indicates, however, an inter-
esting phenotypical simtlanry between the two cell types. 
Ep1dcrmal ~tern cell~. wh1ch are thought to reside in the basal cell 
layrr of mterfollicular epidermiS (34] arc also considered being un-
dlffcremi.ned. Anti gp 38 MoAb did not stain a subset of basal layer 
cells, ~uggestmg that gp 38 ·~not expressed in epidermal stem cells. 
This supports rhe possibility that the two undifferentiated cell types 
-cell\ of epithelial germs and cp1dcrmal stem cells- may be dis-
cnmmated by the usc of a cell-surface marker. 
Other cell~ m normal skm wh1ch also reveal strong gp 38 reactiv-
itv .1re located Ill the secretory tubules of sweat glands. In these cells, 
gp 38 cxprcss1on IS conmtutively high and we speculate that this is 
controlled by different regulatory mechanisms than the "transient" 
exprcs'>IOn of gp 38 in undifferentiated germ cells during the hair 
cycle . 
. Recently, Linnenbach et al (35Jmolecularly cloned the cell-sur-
face glycoprotcm GA733, wh1ch IS lnghly expressed by human 
colon carcmomas. This molecule was shown by Thampoe et al [36] 
to carry gp 38 cp1topes and appears to be the same protem. So far, rhe 
compart\011 of its sequence With sequences of ocher known genes 
has not prov1ded hints for 1ts function. 
In conclusion, we have found that a 38-kD cell-surface glycopro-
tcm is highly increased m 111 vitro and in vivo transformed human 
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Figure 7. High cxprc~sion of gp 38m secondary epathe!.al germs of tdogenac haar follicles. lmmunotluorc:scencc swnmg mang MoAb 1199. Note: strong 
re~criviry IS selecnvelv found an the secondary germ buds. The dascotJIItJUI>IH /irrts mark the: basement membrane of the outer root sheath; arrowheads mdicate the 
stratum corneum of the c:padermas. Magmlication: a and c, X250; b, X 100. 
kcracinocytes buc not an fibroblascs. In normal eptdernus and an 
epithelial sbn tumors, gp 38 reveals a unique express1on patccrn and 
appears rcscncccd co cells lacking squamous and ptlosebaccous dif-
ferentiation. 
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